期刊
JOURNAL OF ORTHOPAEDIC RESEARCH
卷 27, 期 5, 页码 602-611出版社
WILEY
DOI: 10.1002/jor.20787
关键词
BMP-7; osteoarthritis; sheep; impact injury; knee
类别
资金
- Stryker Biotech LLC
- Canadian Arthritis Network
- Canadian Institutes for Health Research [QNT 68722]
In vivo studies were used to characterize a model of cartilage injury leading to osteoarthritis progression in the medial femorotibial joint of sheep. In three subsequent studies, bilateral impact injuries were created and one joint received intraarticular injections of 340 mu g of rhBMP-7 protein in a collagen particle carrier while the contralateral knee received the vehicle alone. Sheep were allocated to three groups that received intraarticular injections on day 0 (group A), 21 (group B), or 90 (group C) after experimental knee injury. In each group the, joints were evaluated for signs of osteoarthritis progression 90 days after the last treatment, using India ink stained area, OARSI histological scoring, cartilage sGAG content, immunostaining for apoptosis (TUNEL), caspase-3, collagen degradation (Col 2 3/4C short collagen epitope), and the endogenous, (pro-) form of BMP-7 protein. Knee joints that received rhBMP-7 immediately after injury had small local lesions at the injury site that did not progress into the surrounding cartilage. Joints that received BMP-7 3 weeks after injury were unproved and had limited progression compared to control, but joints that received the protein 12 weeks after injury had no statistically significant improvement. These studies suggest that BMP-7 may be chondroprotective after traumatic injury in patients if it is administered within 3 to 4 weeks of the index injury. The mechanism of protection after sublethal injury appeared to be an increased survival of chondrocytes that are able to participate in the repair process. (C) 2008 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 27:602-611, 2009
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据